Litigation Details for Bristol-Myers Squibb Company v. Apotex Inc. (D. Del. 2017)
✉ Email this page to a colleague
Bristol-Myers Squibb Company v. Apotex Inc. (D. Del. 2017)
Docket | ⤷ Sign Up | Date Filed | 2017-10-24 |
Court | District Court, D. Delaware | Date Terminated | 2018-02-13 |
Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
Jury Demand | None | Referred To | |
Patents | 6,087,383 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Bristol-Myers Squibb Company v. Apotex Inc.
Details for Bristol-Myers Squibb Company v. Apotex Inc. (D. Del. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2017-10-24 | 1 | ”), prior to expiration of U.S. Patent No. 6,087,383 (“the ’383 patent”). …. This is an action for patent infringement arising under the patent laws of the United States, … PATENT-IN-SUIT 10. On July 11, 2000, the U.S. Patent and Trademark Office…copy of the ’383 patent is attached hereto as Exhibit A. The claims of the ’383 patent are valid and enforceable…of the ’383 patent and has the right to enforce it. The expiration date of the ’383 patent is December | External link to document | |
2018-07-20 | 11 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number US 6,087,383. (etg) (Entered: 07… 14 February 2018 1:17-cv-01493 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2017-10-24 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,087,383. (lmm) (Entered: … 14 February 2018 1:17-cv-01493 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |